This brand name is authorized in South Africa
The drug RHEUMOX contains one active pharmaceutical ingredient (API):
|
1
Azapropazone
UNII K2VOT966ZI - APAZONE
|
|
Azapropazone is a nonsteroidal anti-inflammatory drug (NSAID) used in the treatment of rheumatoid arthritis. It also has uricosuric properties and has been used to treat gout. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| M01AX04 | Azapropazone | M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AX Other antiinflammatory and antirheumatic agents, non-steroids |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: ZA | Health Products Regulatory Authority | Identifier(s): E/3.1/221 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
